Anti EGFR Antibodies
Epidermal growth factor receptor (EGFR) binds to EGF and belongs to the ErbB family of receptor tyrosine kinases. EGFR is crucial for cell proliferation, and mutations or overexpression of EGFR have been observed in various types of human cancers. Notably, EGFR overexpression is associated with the progression, metastasis, and poor prognosis of cancers, including head and neck cancer, lung cancer, and colorectal cancer.
Fujifilm Wako offers mouse monoclonal antibodies against human EGFR, suitable for use in immunohistochemistry, flow cytometry, and Western blotting.
What is EGFR?
Epidermal growth factor receptor (EGFR) binds to EGF and belongs to the ErbB family of receptor tyrosine kinases. The ErbB family includes EGFR (ErbB1, HER1), as well as ErbB2 (HER2), ErbB3 (HER3), and ErbB4 (HER4). When a ligand binds to EGFR, it facilitates dimerization with another ErbB family receptor, resulting in the phosphorylation of tyrosine residues at EGFR autophosphorylation sites. This triggers downstream signaling, leading to the activation of gene expression and other cellular processes. The downstream signaling pathways of EGFR include the MAPK, PI3K/Akt, and Jak/STAT pathways.
EGFR is crucial for cell proliferation, and mutations or overexpression of EGFR have been observed in various types of human cancers. Notably, EGFR overexpression is associated with the progression, metastasis, and poor prognosis of cancers, including head and neck cancer, lung cancer, and colorectal cancer1). Inhibitors targeting EGFR have been approved as therapeutic agents for treating cancers, including non-small cell lung cancer.
Anti Human EGFR, Monoclonal Antibody (EMab-134)
Anti Human EGFR, Monoclonal Antibody (EMab-134) is a mouse monoclonal antibody against human EGFR2). It is suitable for use in immunohistochemistry, flow cytometry, and Western blotting.
Antibody Information
Clonality | Monoclonal |
---|---|
Antigen | Human EGFR, recombinant [extracellular domain] expressed in LN229 Cell Line |
Host | Mouse |
Formulation | PBS, 0.1% sodium azide |
Concentration | 1.0 mg/mL |
Subclass | IgG1・κ |
Conjugate | Unconjugated |
Cross-reactivity | Human |
Application | Flow cytometry: 1-10 μg/mL IHC: 5 μg/mL WB: 1 μg/mL |
Application Data
Immunohistochemistry
Sample: Mouth cancer tissue
Antibody concentration: 5 μg/mL
Western Blotting
Antibody concentration: 1 μg/mL
2nd antibody, detection: Envision+ (Agilent Technologies, Inc.)
References
- Mendelsohn, J.: Endocrine-Related Cancer, 8(1), 3(2001).
The epidermal growth factor receptor as a target for cancer therapy - Itai, S. et al.: Monoclon. Antib. Immunodiagn. Immunother., 36(6), 272(2017).
Establishment of EMab-134, a sensitive and specific anti-epidermal growth factor receptor monoclonal antibody for detecting squamous cell carcinoma cells of the oral cavity
Product List
- Open All
- Close All
Anti Human EGFR, Monoclonal Antibody (EMab-134)
For research use or further manufacturing use only. Not for use in diagnostic procedures.
Product content may differ from the actual image due to minor specification changes etc.
If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.